Ragusa Robert's most recent trade in Twist Bioscience Corp was a trade of 5,095 Common Stock done . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2026 | 5,095 | 28,983 (0%) | 0% | 0 | Common Stock | |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 95.28 per share. | 03 Dec 2025 | 15,356 | 697,866 | - | 95.3 | 1,463,092 | Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 94.43 per share. | 03 Dec 2025 | 14,807 | 713,222 | - | 94.4 | 1,398,249 | Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 96.22 per share. | 03 Dec 2025 | 8,233 | 689,633 | - | 96.2 | 792,152 | Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 97.28 per share. | 03 Dec 2025 | 1,604 | 688,029 | - | 97.3 | 156,042 | Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.88 per share. | 15 Oct 2025 | 7,239 | 727,388 | - | 68.9 | 498,622 | Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 33.93 per share. | 02 May 2025 | 94,035 | 734,627 | - | 33.9 | 3,190,608 | Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 11 Mar 2025 | 7,625 | 828,662 | - | 31.2 | 237,976 | Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.21 per share. | 07 Mar 2025 | 7,625 | 828,662 | - | 31.2 | 237,976 | Common Stock |
| GRAIL Inc | Robert Ragusa | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.51 per share. | 05 Mar 2025 | 994 | 836,287 | - | 41.5 | 41,261 | Common Stock |
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 4,472 | 23,888 (0%) | 0% | 0 | Common Stock | |
| GRAIL Inc | Robert Ragusa | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 28.84 per share. | 03 Feb 2025 | 224,620 | 837,281 | - | 28.8 | 6,478,041 | Common Stock |
| GRAIL Inc | Robert Ragusa | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.02 per share. | 15 Oct 2024 | 123,454 | 612,661 | - | 14.0 | 1,730,825 | Common Stock |
| GRAIL Inc | Robert Ragusa | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 12.57 per share. | 03 Oct 2024 | 214,240 | 690,275 | - | 12.6 | 2,692,997 | Common Stock |
| GRAIL Inc | Robert Ragusa | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 12.57 per share. | 03 Oct 2024 | 45,840 | 736,115 | - | 12.6 | 576,209 | Common Stock |
| GRAIL Inc | Robert Ragusa | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 475,178 | 476,035 | - | 0 | Common Stock | |
| Twist Bioscience Corp | Ragusa Robert | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 5,815 | 19,416 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 8,212 | 13,601 (0%) | 0% | 0 | Common Stock | |
| Twist Bioscience Corp | Robert Ragusa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2022 | 3,491 | 5,389 (0%) | 0% | 0 | Common Stock |